Tango Therapeutics

TNGXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.765 B

$22.33 +2.67%

Close of 21 Sept 2026

Revenue

$62.4M

#2662 by revenue

Earnings

-$101.6M

Loss-making

Shares outstanding

168,610,367

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#65Telix PharmaceuticalsTLX$3.83B
#66Xenon PharmaceuticalsXENE$3.78B
#67Tango TherapeuticsTNGX$3.77B
#68IDEAYA BiosciencesIDYA$3.75B
#69Legend BiotechLEGN$3.60B

What if Tango Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$179,550.37

Per share 8,041× higher

Bitcoin $1.72T

$10,199.87

Per share 457× higher

Nvidia $5.48T

$32,500.12

Per share 1,455× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Tango Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.